Company & Sponsor Intelligence

Medical University of Warsaw

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting1

Completed1

Countries1

Therapeutic footprint

adhdepilepsyparkinsons

Indexed studies

NCT03486366Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.
epilepsy · PolandNA

NCT02114632Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
adhd · PolandPHASE1, PHASE2

NCT06834191Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease
parkinsons · PolandRECRUITING

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →